Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
Shares in R&D company Midatech Pharma (NASDAQ:MTP) have surged after the company announced its registration statement has been declared effective by the US Securities and Exchange Commission (SEC).
Its US-listed shares are currently trading at $3.25 premarket, up 73.80%, while its London-listed shares are up 39% so far today at 44.6p per share.
The registration statement on the form F-1 relates to the permitted resale of up to 12,695,445 ordinary shares with a nominal value of 0.1p, which is represented by 2,539,091 American Depositary Shares (ADS).
The form F-1 registration statement form is commonly used by foreign private companies (non-US companies) that are selling securities in a registered offering in the US for the first time.
The registration statement, while it remains active, allows the stockholders named to publicly resell the ADS’s or ordinary shares with the company not receiving any of the proceeds from the sale.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .